Morgan Stanley flags vital Eli Lilly signal for 2026
Picture a drug so popular that, even in markets where a cheaper generic competitor had just launched[……] Read More
Eli Lilly stock swings after FDA liver failure report for GLP-1 drug
Eli Lilly (LLY) stock initially sold off on Monday morning, May 4, after the FDA disclosed a liver f[……] Read…